…Chronic obstructive pulmonary disease (COPD) is mainly treated with bronchodilators (long-acting beta…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 255 of 2459… was done. Most common primary tumours were melanoma (n=62) and non-small cell lung cancer (n=51). PD-1 inhibitors (n=208) were the commonest monotherapy,…
… inhibitors (GPIs) were initially used prior to angiography for acute coronary syndrome (ACS). Contemporary European Society of Cardiology (ESC) guidan…
…ibitor (SGLT2i), n (%) 43 (51.8) Loop diuretic, n (%) 55 (66.3) Amiodarone, n (%) 19 (22.9) Optimised on all heart failure medications, n …
…Background/Introduction Amiodarone is a widely used class III anti-arrhythmic drug that is highly …
…fect bacterial cells by hijacking their genome, inducing lysis. Phage therapy targets drug resistant pathogens whilst retaining selective tox…
…ithin the treated sub cohort, and only 14 within the controlled hypertension sub cohort (refer to figure 1) . Our PheWAS analysis showed tha…
…ween 2012 and 2022Conclusions Overall declines in most types of cardiovascular disease mask an increasing burden of cardiovascular events relating to …
…explore this relationship.Methods Patients who were admitted to Oxford University Hospital with ACS were consented to the INFLAMED study. Continuous gluco…
…sulin resistance, are major risk factors for the development of cardiomyopathy and heart failure. The development of these diseases is signifi…
… the cornerstone of treatment for advanced-stage disease. While lenvatinib has been a widely used first-line agent, the advent of immunoth…
…luations conducted globally, comparing SAT to FB DOTS regarding TB patient costs. Grey literature will be included. Exclusion crit…